Be the first to know

Never miss an update from NanoViricides. Did you know that during reporting season, the announcements from NYSEMKT:NNVC often move the market?

NanoViricides (NYSEMKT:NNVC) Company Logo

By joining StockLight, you agree to our Terms & Conditions and Privacy Policy
Create Alert Follow NNVC

NanoViricides (NNVC)

US NYSEMKT:NNVC (38.9M)

5.45
+0.21 (3.81%)
10:33am EDT
LOADING
Loading price chart..

Summary

Current Price: $5.45
52w High/Low: $1.27 - 19.2
Market Cap: 38.9M
Price/Earnings: -2.63
Dividend Yield: -
Volume/Average: 170K - 1.5M
NanoViricides (NYSEMKT:NNVC) Company Logo
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses... More
NanoViricides (NYSEMKT:NNVC) Company Logo

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Annual Reports

NanoViricides (NNVC) 10-K Annual Report Aug 23rd 2019
2019
(1.2mb)
NanoViricides (NNVC) 10-K Annual Report Oct 12th 2018
2018
(1.3mb)
NanoViricides (NNVC) 10-K Annual Report Sep 28th 2018
2018
(439kb)
NanoViricides (NNVC) 10-K Annual Report Sep 28th 2017
2017
(926kb)
NanoViricides (NNVC) 10-K Annual Report Sep 16th 2016
2016
(1.2mb)

Dividend History

No dividends found.

Quantitative Ratios

Stock Ratios Locked
You viewed 3 companies today
Ratios will be unlocked
again tomorrow or;

Unlock these ratios,
configure alerts
and much more...

Download StockLight

All Ratios, Alerts and other features are available in our iOS and Android apps:
Download on iOS Download on Android

We are working on updating this web app to fully enable Quantitative Ratios. All other current web features including annual reports, price sensitive announcements, dividends and earnings transcripts are free to use here on our web app.
Implied Growth
69.2%
 
50.9%
 
 
Industry Avg
NNVC

ATTRACTIVE: NanoViricides exhibits an implied growth ratio which is less than the industry average for biotechnology stocks listed on the NYSEMKT. NNVC calculation: 10% - (-$2.13 / $5.45) = 49.1% more
Price / Book
3.0
 
4.9
 
 
Industry Avg
NNVC

UNATTRACTIVE: NanoViricides exhibits a price/book ratio which exceeds the industry average for biotechnology stocks listed on the NYSEMKT. more

Company News

No company news found